First Time Loading...

Lyra Therapeutics Inc
NASDAQ:LYRA

Watchlist Manager
Lyra Therapeutics Inc Logo
Lyra Therapeutics Inc
NASDAQ:LYRA
Watchlist
Price: 0.3558 USD -4.35% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

141.5m
-0.8%
Assets
Growth Rates:
1 Year
+51%
3 Years
+94%
5 Years
-
7 Years
-
10 Years
-
64m
+20%
Liabilities
Growth Rates:
1 Year
+130%
3 Years
+1 086%
5 Years
-
7 Years
-
10 Years
-
77.5m
-13%
Equity
Growth Rates:
1 Year
+17%
3 Years
+15%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Lyra Therapeutics Inc

141.5m
Assets
64m
Liabilities
141.5m
Assets
64m
Liabilities
Current Assets 89.4m
Cash & Short-Term Investments 87.1m
Other Current Assets 2.3m
Non-Current Assets 52.1m
PP&E 49.4m
Other Non-Current Assets 2.7m
Current Liabilities 18.7m
Accounts Payable 2.8m
Accrued Liabilities 14.6m
Other Current Liabilities 1.3m
Non-Current Liabilities 45.3m
Other Non-Current Liabilities 45.3m

Balance Sheet
Lyra Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
24
10
75
46
33
22
Cash Equivalents
24
10
75
46
33
22
Short-Term Investments
0
0
0
0
65
80
Total Receivables
0
0
0
0
0
0
Other Current Assets
1
0
1
2
3
2
Total Current Assets
25
10
76
48
101
105
PP&E Net
0
3
5
6
5
35
PP&E Gross
0
3
5
6
5
35
Accumulated Depreciation
3
3
3
4
4
2
Other Long-Term Assets
0
1
0
1
5
3
Total Assets
25
N/A
15
-41%
81
+439%
55
-32%
110
+100%
143
+30%
Liabilities
Accounts Payable
1
1
1
3
3
3
Accrued Liabilities
1
4
4
5
11
15
Short-Term Debt
0
0
0
0
0
0
Other Current Liabilities
0
0
0
10
1
2
Total Current Liabilities
2
5
5
18
15
20
Long-Term Debt
0
0
0
0
0
0
Other Liabilities
0
2
2
2
15
34
Total Liabilities
2
N/A
8
+262%
6
-17%
21
+227%
29
+42%
53
+82%
Equity
Common Stock
130
131
0
0
0
0
Retained Earnings
112
128
150
193
249
311
Additional Paid In Capital
4
4
224
228
329
401
Other Equity
0
0
0
0
0
0
Total Equity
23
N/A
7
-69%
75
+921%
34
-54%
81
+136%
89
+11%
Total Liabilities & Equity
25
N/A
15
-41%
81
+439%
55
-32%
110
+100%
143
+30%
Shares Outstanding
Common Shares Outstanding
12
12
13
13
32
57

See Also

Summary
LYRA intrinsic value, competitors valuation, and company profile.
DCF Valuation
LYRA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LYRA stock valuation using valuation multiples.
Wall Street Estimates
LYRA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LYRA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.